Related Experiment Video
Updated: Jan 4, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Treatment of Differentiated Thyroid Carcinomas
Melissa G Lechner1, Stephanie Smooke Praw2, Trevor E Angell3
1Division of Endocrinology, Diabetes, and Metabolism, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, CHS 57-145, Los Angeles, CA 90095, USA.
Differentiated thyroid cancer (DTC) incidence is rising. Treatment options include surgery, radioactive iodine (RAI), and levothyroxine, with active surveillance for low-risk cases and novel agents for metastatic disease.
Area of Science:
- Oncology
- Endocrinology
Background:
- Differentiated thyroid cancer (DTC) is the most common endocrine malignancy.
- Significant increase in DTC incidence over the past 30 years.
- Standard treatments include surgery, radioactive iodine (RAI), and levothyroxine suppression therapy.
Purpose of the Study:
- To review current management strategies for differentiated thyroid cancer.
- To discuss the role of active surveillance and novel therapeutic agents.
Main Methods:
- Literature review of clinical practice guidelines and recent studies.
- Analysis of treatment modalities based on patient characteristics and disease stage.
Main Results:
- Active surveillance is a viable option for selected low-risk DTC patients.
- Patient factors significantly impact treatment choice and intensity.
- For progressive metastatic DTC unresponsive to surgery or RAI, targeted therapies and immunotherapy are emerging options.
Conclusions:
- Treatment for DTC requires individualized approaches.
- Novel agents offer new hope for patients with advanced or refractory metastatic disease.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...

